Browse Guides  internal medicine  gastroenterology

Inflammatory bowel disease

Prevalence
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Prevention

Crohn's disease

In patients with frequent relapses d give azathioprine (≥ 2.0 mg/kg daily) a

Why?

  • It reduces relapse and steroid use, but adverse effects are common (pancreatitis, leukopenia, nausea, "allergy" and infection) a

Azathioprine helps maintain remission but causes adverse effects

Patient Treatment Comparison Outcome CER OR
(95% CI)
NNT
(95% CI)
Crohn's disease a azathioprine placebo still in remission
at 6-12 months
53% 2.16
(1.35 to 3.47)
6
(4 to 14)
      on 10 mg prednisolone or less per day
at 6-12 months
53% 5.22
(1.06 to 25.68)
3
(2 to 69)
      adverse effects
at 6-12 months
1.6% 4.36
(1.63 to 11.67)
-20
(-100 to -7)

Expiry date: July 2003
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   L   Friedman
CAT Writers   D   Ford , CM   Ball